Fortis Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Fortis Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$618K	Buy	3,908 +2	+0.1%	+$270	0.29%	54
2026 Q1	$499K	Hold	3,906	–	–	0.25%	66
2025 Q4	$476K	Sell	3,906 -770	-16%	-$88.3K	0.26%	65
2025 Q3	$469K	Sell	4,676 -500	-10%	-$45K	0.26%	66
2025 Q2	$429K	Sell	5,176 -774	-13%	-$61.7K	0.27%	68
2025 Q1	$483K	Hold	5,950	–	–	0.31%	60
2024 Q4	$536K	Buy	5,950 +650	+12%	+$63K	0.35%	52
2024 Q3	$524K	Hold	5,300	–	–	0.34%	54
2024 Q2	$491K	Buy	5,300 +1,150	+28%	+$103K	0.35%	45
2024 Q1	$394K	Hold	4,150	–	–	0.26%	61
2023 Q4	$371K	Hold	4,150	–	–	0.26%	61
2023 Q3	$303K	Hold	4,150	–	–	0.23%	71
2023 Q2	$345K	Hold	4,150	–	–	0.25%	63
2023 Q1	$316K	Hold	4,150	–	–	0.21%	68
2022 Q4	$344K	Hold	4,150	–	–	0.26%	62
2022 Q3	$329K	Buy	4,150 +500	+14%	+$42.2K	0.23%	65
2022 Q2	$271K	Buy	3,650 +650	+22%	+$48.8K	0.18%	77
2022 Q1	$270K	Buy	+3,000	New	+$277K	0.15%	84

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Fortis Advisors's XBI Position: Q2 2026 in Review

Fortis Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.05% in Q2 2026, buying an estimated $270 and bringing the position to 3,908 shares worth $618K. The position accounts for 0.29% of the portfolio, ranked #54.

Fortis Advisors first reported a position in XBI in Q1 2022 and has held it in 18 quarters since. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Fortis Advisors held 3,908 shares of State Street SPDR S&P Biotech ETF worth $618K as of Q2 2026.
Fortis Advisors bought 2 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $270.
State Street SPDR S&P Biotech ETF made up 0.29% of Fortis Advisors's portfolio in Q2 2026, its #54 holding.
Fortis Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 18 quarters since.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Fortis Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.